Middle East Healthcare Company

Total Valuation

Middle East Healthcare Company carries a market capitalization of 2.92B, placing it among publicly traded companies globally. Its enterprise value stands at 5.68B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Middle East Healthcare Company currently has 92.04M shares outstanding.

Valuation Ratios

Middle East Healthcare Company trades at a trailing price-to-earnings ratio of 19.06. The price-to-sales ratio is 1.02, and the price-to-book ratio stands at 1.91.

Enterprise Valuation

On an enterprise value basis, Middle East Healthcare Company trades at an EV/EBITDA multiple of 15.53 and an EV/FCF ratio of 4.53. The EV/Sales ratio of 1.81 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 15.53 provides insight into valuation relative to core operating earnings.

Financial Position

Middle East Healthcare Company maintains a current ratio of 1.48, meaning it holds 1.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 126.04, indicating elevated leverage, while an interest coverage ratio of 2.00 demonstrates limited ability to service its debt obligations.

Financial Efficiency

Middle East Healthcare Company posts a return on equity of 10.37 and a return on invested capital of 7.79.

Taxes

Over the trailing twelve months, Middle East Healthcare Company has paid 15.68M in income taxes, reflecting an effective tax rate of 8.36.

Stock Price Statistics

Middle East Healthcare Company's stock has declined approximately -45.41702% over the past 52 weeks. The 50-day moving average sits at 33.52, while the 200-day moving average is 37.81.

Income Statement

Over the trailing twelve months, Middle East Healthcare Company generated 3.13B in revenue and converted that into 167.45M in net income, yielding earnings per share of 1.87. EBITDA reached 365.98M, while operating income came in at 365.98M.

Balance Sheet

Middle East Healthcare Company holds 24.10M in cash and equivalents against 2.46B in total debt, resulting in a net debt position of 2.31B. Total book value stands at 1.67B, with working capital of 699.74M providing operational flexibility.

Cash Flow

Middle East Healthcare Company produced 535.47M in operating cash flow over the past twelve months. After subtracting -552.74M in capital expenditures, free cash flow totaled -17.27M - equivalent to -0.19 per share.

Margins

Middle East Healthcare Company operates with a gross margin of 36.08, reflecting its pricing power and cost economics. The operating margin of 11.68 and net profit margin of 5.34 provide insight into operational efficiency.

Dividends & Yields

Scores

Middle East Healthcare Company posts an Altman Z-Score of 1.70, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.